Premium
Reassessment of clinical implication of pretransplant surgical procedures for pulmonary invasive fungal lesions
Author(s) -
Shingai Naoki,
Kaito Satoshi,
Yamada Yuta,
Konishi Tatsuya,
Nagata Akihito,
Kurosawa Shuhei,
WatakabeInamoto Kyoko,
Igarashi Aiko,
Najima Yuho,
Muto Hideharu,
Kobayashi Takeshi,
Doki Noriko,
Kakihana Kazuhiko,
Sakamaki Hisashi,
Ohashi Kazuteru
Publication year - 2019
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.13023
Subject(s) - medicine , surgery , lung abscess , abscess , exacerbation , transplantation , lung , hematopoietic stem cell transplantation , mortality rate
Dealing with the recent series of allogeneic hematopoietic stem cell transplantation (allo‐SCT) performed this decade, we reassessed the clinical impact of pretransplant surgical procedures (SP) for pulmonary lesions of invasive fungal disease (IFD) on subsequent transplant outcome. We focused on the clinical outcomes of seven patients with pulmonary IFD who underwent segmentectomy (n = 4), lobectomy (n = 2) or abscess incision with drainage only (n = 1), and compared results to those of 21 patients carrying pulmonary IFD who never underwent invasive SP before allo‐SCT. The rate of exacerbation of pulmonary lesions by 180 days after allo‐SCT did not differ significantly between groups (32.2% vs 42.9%, P = 0.69). Moreover, no significant differences in non‐relapse mortality (46.4% vs 42.3%, P = 0.93) or overall survival (53.6% vs 30.9%, P = 0.45) at 1 year were evident between groups. These results indicate that pretransplant SP for pulmonary lesions might have no survival benefit under the current antifungal prophylaxis or treatment modality.